Drug Trial Radar · NCT00278941
Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Mar 25, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,000
Actual
Start
Dec 2005
Primary completion
Not stated
Study completion Aug 2007
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jan 19, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine safety \& efficacy of SEROQUEL SR™ in the treatment of major depressive disorder compared to placebo \& to evaluate quality of sleep, overall quality of life, and effect, if any, on anxiety and satisfaction PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Conditions
- Major Depressive Disorder
Interventions
Quetiapine Fumarate Sustained ReleaseDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of quetiapine SR compared to placebo in increasing time from randomisation to a depressed event in patients with Major Depressive Disorder (MDD)
Locations
168 sites in 8 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Tuscaloosa, Alabama
Research Site
Mesa, Arizona
Research Site
Peoria, Arizona
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Cerritos, California
Research Site
Costa Mesa, California
Research Site
El Centro, California
Research Site
Fresno, California
Research Site
La Mesa, California
Research Site
Los Angeles, California
Research Site
Oceanside, California
Research Site
Pasadena, California
Research Site
Pico Rivera, California
Research Site
Redlands, California
Research Site
Riverside, California
Research Site
San Diego, California
Research Site
Santa Ana, California
Research Site
Stanford, California
Research Site
Torrance, California
Research Site
Upland, California
Research Site
Vista, California
Research Site
Walnut Creek, California
Research Site
Colorado Springs, Colorado
Research Site
Pueblo, Colorado
Research Site
Cromwell, Connecticut
Research Site
Farmington, Connecticut
Research Site
Middletown, Connecticut
Research Site
Wilmington, Delaware
Research Site
Washington D.C., District of Columbia
Research Site
Altamonte Springs, Florida
Research Site
Clearwater, Florida
Research Site
Coral Springs, Florida
Research Site
DeLand, Florida
Research Site
Fort Myers, Florida
Research Site
Gainsville, Florida
Research Site
Hialeah, Florida
Research Site
Jacksonville, Florida
Research Site
Miami, Florida
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.